This report describes a case of biopsy-confirmed EGPA in which early initiation of mepolizumab, guided by biomarker surveillance, resulted in steroid-free MPO-ANCA seroconversion. Here, MPO is linked to eosinophilic granulomatosis with polyangiitis.